does midi health prescribe tirzepatide The FDA has approved oral Wegovy—a daily pill option for weight loss that uses semaglutide, the same active ingredient as injectable GLP-1s. As Midi's Chief Medical Officer, Dr. Kathleen Jordan explains: if Tirzepatide vs. Retatrutide: Key Differences
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4















01022-6/asset/952d7e95-2087-4775-a83f-0bb8fbd27531/main.assets/gr1_lrg.jpg)








